Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)
Clinical trial NCT00002224 · COMPLETED
Trial details
- NCT number
- NCT00002224
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-03-01
- Primary completion
- 1999-03-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.